255 related articles for article (PubMed ID: 20031381)
1. Metabolic toxicity of the heart: insights from molecular imaging.
Iozzo P
Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):147-56. PubMed ID: 20031381
[TBL] [Abstract][Full Text] [Related]
2. Diabetes-related metabolic perturbations in cardiac myocyte.
Feuvray D; Darmellah A
Diabetes Metab; 2008 Feb; 34 Suppl 1():S3-9. PubMed ID: 18358420
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism.
Qi D; Rodrigues B
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E654-67. PubMed ID: 17077342
[TBL] [Abstract][Full Text] [Related]
4. Contribution of tissue acidosis to ischemic injury in the perfused rat heart.
Williamson JR; Schaffer SW; Ford C; Safer B
Circulation; 1976 Mar; 53(3 Suppl):I3-14. PubMed ID: 3293
[TBL] [Abstract][Full Text] [Related]
5. Cardiac fatty acid metabolism and ischemic memory imaging with nuclear medicine techniques.
Palaniswamy SS; Padma S
Nucl Med Commun; 2011 Aug; 32(8):672-7. PubMed ID: 21606884
[TBL] [Abstract][Full Text] [Related]
6. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
7. Cardiac energetics during ischaemia and the rationale for metabolic interventions.
Stanley WC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S3-7. PubMed ID: 11286306
[TBL] [Abstract][Full Text] [Related]
8. Targets for modulation of fatty acid oxidation in the heart.
Lopaschuk GD
Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
[TBL] [Abstract][Full Text] [Related]
9. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart.
Briede J; Stivrina M; Vigante B; Stoldere D; Duburs G
Cell Biochem Funct; 2008; 26(2):238-45. PubMed ID: 17990288
[TBL] [Abstract][Full Text] [Related]
10. Diabetic cardiomyopathy.
Feuvray D
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):261-5. PubMed ID: 15106750
[TBL] [Abstract][Full Text] [Related]
11. Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease.
Beadle RM; Frenneaux M
Heart; 2010 Jun; 96(11):824-30. PubMed ID: 20478861
[TBL] [Abstract][Full Text] [Related]
12. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography.
Karamitsos TD; Leccisotti L; Arnold JR; Recio-Mayoral A; Bhamra-Ariza P; Howells RK; Searle N; Robson MD; Rimoldi OE; Camici PG; Neubauer S; Selvanayagam JB
Circ Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 19920032
[TBL] [Abstract][Full Text] [Related]
13. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid metabolism in obesity and type 2 diabetes mellitus.
Blaak EE
Proc Nutr Soc; 2003 Aug; 62(3):753-60. PubMed ID: 14692611
[TBL] [Abstract][Full Text] [Related]
15. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
16. Alterations in myocardial metabolism in the diabetic myocardium.
Lazar HL
Semin Thorac Cardiovasc Surg; 2006; 18(4):289-92. PubMed ID: 17395024
[TBL] [Abstract][Full Text] [Related]
17. Metabolic remodelling of the failing heart: beneficial or detrimental?
van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
[TBL] [Abstract][Full Text] [Related]
18. Heart metabolic disturbances in cardiovascular diseases.
Carvajal K; Moreno-Sánchez R
Arch Med Res; 2003; 34(2):89-99. PubMed ID: 12700003
[TBL] [Abstract][Full Text] [Related]
19. Metabolic support as an adjunct to inotropic support in the hypoperfused heart.
Saupe KW; Eberli FR; Ingwall JS; Apstein CS
J Mol Cell Cardiol; 2001 Feb; 33(2):261-9. PubMed ID: 11162131
[TBL] [Abstract][Full Text] [Related]
20. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.
Mather KJ; Hutchins GD; Perry K; Territo W; Chisholm R; Acton A; Glick-Wilson B; Considine RV; Moberly S; DeGrado TR
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E452-60. PubMed ID: 26732686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
